"Hyaluronoglucosaminidase" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An enzyme that catalyzes the random hydrolysis of 1,4-linkages between N-acetyl-beta-D-glucosamine and D-glucuronate residues in hyaluronate. (From Enzyme Nomenclature, 1992) There has been use as ANTINEOPLASTIC AGENTS to limit NEOPLASM METASTASIS.
| Descriptor ID |
D006821
|
| MeSH Number(s) |
D08.811.277.450.529 D08.811.520.241.700.675
|
| Concept/Terms |
Hyaluronoglucosaminidase- Hyaluronoglucosaminidase
- Hyaluronidase
- Hyaglosidase
- Hyaluronate Hydrolase
- Hydrolase, Hyaluronate
- Duran-Reynals Permeability Factor
- Duran Reynals Permeability Factor
- Factor, Duran-Reynals Permeability
- Permeability Factor, Duran-Reynals
- GL Enzyme
|
Below are MeSH descriptors whose meaning is more general than "Hyaluronoglucosaminidase".
Below are MeSH descriptors whose meaning is more specific than "Hyaluronoglucosaminidase".
This graph shows the total number of publications written about "Hyaluronoglucosaminidase" by people in this website by year, and whether "Hyaluronoglucosaminidase" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 1 | 0 | 1 |
| 1995 | 1 | 0 | 1 |
| 1996 | 1 | 0 | 1 |
| 1999 | 3 | 1 | 4 |
| 2002 | 0 | 1 | 1 |
| 2004 | 1 | 0 | 1 |
| 2005 | 1 | 1 | 2 |
| 2007 | 1 | 2 | 3 |
| 2008 | 0 | 1 | 1 |
| 2009 | 1 | 1 | 2 |
| 2012 | 1 | 1 | 2 |
| 2013 | 1 | 0 | 1 |
| 2016 | 0 | 1 | 1 |
| 2017 | 1 | 0 | 1 |
| 2019 | 1 | 0 | 1 |
| 2020 | 0 | 1 | 1 |
| 2021 | 2 | 1 | 3 |
| 2022 | 0 | 1 | 1 |
| 2023 | 0 | 3 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Hyaluronoglucosaminidase" by people in Profiles.
-
Atezolizumab Plus PEGPH20 Versus Chemotherapy in Advanced Pancreatic Ductal Adenocarcinoma and Gastric Cancer: MORPHEUS Phase Ib/II Umbrella Randomized Study Platform. Oncologist. 2023 06 02; 28(6):553-e472.
-
Targeting BET Proteins Decreases Hyaluronidase-1 in Pancreatic Cancer. Cells. 2023 05 27; 12(11).
-
Multispectroscopic, virtual and in vivo insights into the photoaging defense mediated by the natural food colorant bixin. Food Funct. 2023 Jan 03; 14(1):319-334.
-
Hyaluronidase for Skin Necrosis Induced by Amiodarone. Cutis. 2022 10; 110(4):E33-E35.
-
Skin-specific knockdown of hyaluronan in mice by an optimized topical 4-methylumbelliferone formulation. Drug Deliv. 2021 Dec; 28(1):422-432.
-
Elucidating the clinical spectrum and molecular basis of HYAL2 deficiency. Genet Med. 2022 03; 24(3):631-644.
-
Hyaluronidases in Human Diseases. Int J Mol Sci. 2021 Mar 22; 22(6).
-
Pancreatic cancer stroma: an update on therapeutic targeting strategies. Nat Rev Gastroenterol Hepatol. 2020 08; 17(8):487-505.
-
Hyaluronidase-Assisted Resuscitation in Kenya for Severely Dehydrated Children. Pediatr Emerg Care. 2019 Oct; 35(10):692-695.
-
Whole exome sequencing in the Framingham Heart Study identifies rare variation in HYAL2 that influences platelet aggregation. Thromb Haemost. 2017 06 02; 117(6):1083-1092.